Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery
Status:
Unknown status
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
Our aim is to test whether short term perioperative administration of oral spironolactone
could reduce incidence of postoperative acute kidney injury (AKI) in cardiac surgical
patients.
Phase:
N/A
Details
Lead Sponsor:
Instituto Nacional de Cardiologia Ignacio Chavez
Collaborator:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran